Share Your Story

Share your story and help other adults learn about XELJANZ. Learning about your experience with XELJANZ may be helpful for patients who are considering treatment or have already started. If selected, your story may appear on XELJANZ.com and/or in other marketing materials.

  • Moderate to SevereRheumatoid Arthritis
  • ActivePsoriatic Arthritis
  • Moderate to SevereUlcerative Colitis

IN ORDER TO SUBMIT YOUR STORY, YOU MUST:

  • Be 18 years or older
  • Have been diagnosed with moderate to severe RA
  • Not be enrolled in a current Pfizer clinical trial
  • Have taken a tumor necrosis factor (TNF) blocker before XELJANZ or XELJANZ XR
  • Have been taking XELJANZ or XELJANZ XR for a minimum of 8 weeks
  • Be a resident of the United States
  • Be 18 years or older
  • Have been diagnosed with active psoriatic arthritis
  • Not be enrolled in a current Pfizer clinical trial
  • Have taken a tumor necrosis factor (TNF) blocker before XELJANZ or XELJANZ XR
  • Have been taking XELJANZ or XELJANZ XR for your active psoriatic arthritis in combination with a nonbiologic DMARD*
  • Be a resident of the United States
*Methotrexate, sulfasalazine, or leflunomide
  • Be 18 years or older
  • Have been diagnosed with moderate to severe ulcerative colitis
  • Not be enrolled in a current Pfizer clinical trial
  • Have taken a tumor necrosis factor (TNF) blocker before XELJANZ or XELJANZ XR
  • Have been taking XELJANZ or XELJANZ XR for a minimum of 8 weeks
  • Be a resident of the United States